Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2018, Article ID 5962624, 22 pages
Research Article

Evaluating IL-21 as a Potential Therapeutic Target in Crohn’s Disease

1Global Research, Novo Nordisk A/S, Maaloev, Denmark
2Novo Nordisk LIFE In Vivo Pharmacology Centre, Frederiksberg, Denmark

Correspondence should be addressed to Thomas Lindebo Holm; moc.ksidronovon@hlht

Received 9 August 2017; Revised 5 February 2018; Accepted 13 February 2018; Published 10 April 2018

Academic Editor: Paul Enck

Copyright © 2018 Thomas Lindebo Holm et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Thomas Lindebo Holm, Ditte Tornehave, Henrik Søndergaard, et al., “Evaluating IL-21 as a Potential Therapeutic Target in Crohn’s Disease,” Gastroenterology Research and Practice, vol. 2018, Article ID 5962624, 22 pages, 2018.